What is Tirzepatide?
Tirzepatide is a medication that belongs to a class known as GLP-1 and GIP receptor agonists. It works by improving blood sugar control and suppressing appetite, which can help with weight loss.
Mounjaro and Zepbound – What’s the Difference?
- Mounjaro: Primarily used for the treatment of type 2 diabetes to help control blood sugar. It is injected once a week and often results in weight loss as a side effect.
- Zepbound: Specifically approved for weight loss and contains a higher dosage of Tirzepatide. It is also administered as a weekly injection.
Standard Dosage for Weight Loss (Zepbound)
Like other similar medications, the dosage starts low and gradually increases to reduce the risk of side effects:- Week 1-4: 2.5 mg per week
- Week 5-8: 5 mg per week
- Week 9-12: 7.5 mg per week
- Week 13-16: 10 mg per week
- Week 17-20: 12.5 mg per week
- Week 21+: 15mg (target dose)
Possible Side Effects
Tirzepatide can also cause side effects, and here are some potential ones:- Nausea and vomiting
- Diarrhea or constipation
- Fatigue
- Abdominal pain
- Loss of appetite
- Gallstones (with long-term use)
- Injection site reactions (for injections)
Last edited: